We are live on ! Find out more
IHE icon

iShares US Pharmaceuticals ETF
IHE

120 hedge funds and large institutions have $404M invested in iShares US Pharmaceuticals ETF in 2015 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 35 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 9

29% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 35

8% more funds holding

Funds holding: 111 → 120 (+9)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

8% less capital invested

Capital invested by funds: $441M → $404M (-$36.7M)

11.89% less ownership

Funds ownership: 116.14% → 104.24% (-12%)

Holders
120
Holders Change
+9
Holders Change %
+8.11%
% of All Funds
3.23%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
19
Increased
45
Reduced
35
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RJA
Raymond James & Associates
Florida
+$5.97M
2
Citadel Advisors
Citadel Advisors
Florida
+$4.32M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$3.74M
4
UFF
USA Financial Formulas
Michigan
+$3.73M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.66M

Top Sellers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$54.5M
2
BHB
Bank Hapoalim BM
Israel
-$9.59M
3
RJFSA
Raymond James Financial Services Advisors
Florida
-$8.85M
4
AWA
ARS Wealth Advisors
Florida
-$3.81M
5
SG Americas Securities
SG Americas Securities
New York
-$3.11M
Name Holding Trade Value Shares
Change 		Change in
Stake
CIBC World Market
26
CIBC World Market
Ontario, Canada
$2.74M +$971K +16,620 +55%
AP
27
Advisors Preferred
Maryland
$2.67M +$2.38M +40,656 +786%
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$2.65M +$2.66M +45,537 New
EC
29
Estate Counselors
Wisconsin
$2.54M -$105K -1,800 -4%
Stifel Financial
30
Stifel Financial
Missouri
$2.46M +$230K +3,942 +10%
VFS
31
VSR Financial Services
Kansas
$2.27M +$492K +8,424 +28%
ACM
32
Avalon Capital Management
California
$2.23M -$2.62M -44,898 -54%
PP
33
Patten & Patten
Tennessee
$2.15M -$98.1K -1,680 -4%
CAN
34
Cetera Advisor Networks
California
$2.03M – – –
NCM
35
Niemann Capital Management
Nevada
$1.98M +$1.99M +34,023 New
NPC
36
National Planning Corporation
California
$1.87M +$1.15M +19,695 +160%
CFA
37
Cahill Financial Advisors
Minnesota
$1.71M -$6.13K -105 -0.4%
CPC
38
Cookson Peirce & Co
Pennsylvania
$1.69M +$45.6K +780 +3%
TRCT
39
Tower Research Capital (TRC)
New York
$1.48M +$616K +10,545 +71%
SPC
40
Sigma Planning Corp
Michigan
$1.43M +$173K +2,967 +14%
JP Morgan Chase
41
JP Morgan Chase
New York
$1.35M -$49.6K -849 -4%
ICOA
42
Investment Centers of America
North Dakota
$1.28M +$37.7K +645 +3%
SAM
43
Stringer Asset Management
Tennessee
$1.27M +$195K +3,345 +18%
KCM
44
Karp Capital Management
California
$1.26M +$56.1K +960 +5%
PAMU
45
Pictet Asset Management (UK)
United Kingdom
$1.22M -$473K -8,100 -29%
AMG
46
Asset Management Group
Connecticut
$1.2M +$1.93K +33 +0.2%
Bank of Montreal
47
Bank of Montreal
Ontario, Canada
$1.17M -$54.5M -933,621 -98%
HH
48
Hilltop Holdings
Texas
$1.13M +$199K +3,411 +21%
SI
49
SII Investments
Wisconsin
$1.08M +$94.5K +1,617 +10%
Koshinski Asset Management
50
Koshinski Asset Management
Illinois
$1.02M -$51.7K -885 -5%
1
2
3 4 5

IHE Hedge Fund Activity: Q2 2015 in Review

120 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in iShares US Pharmaceuticals ETF (IHE) for Q2 2015, worth a combined $404M — down 8.3% from $441M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new IHE positions and 9 closed out — a net gain of 10 holders — while 45 added to existing stakes and 35 trimmed.

The largest buyer was Raymond James & Associates, adding an estimated $5.97M. The largest seller was Bank of Montreal, cutting an estimated $54.5M.

  • 120 institutional investors held iShares US Pharmaceuticals ETF (IHE) as of Q2 2015, up from 111 in Q1 2015.
  • Funds reported $404M of iShares US Pharmaceuticals ETF stock for Q2 2015, down 8.3% quarter-over-quarter.
  • 19 funds opened new iShares US Pharmaceuticals ETF positions in Q2 2015 and 9 closed out, a net change of +10 holders.
  • The largest iShares US Pharmaceuticals ETF buyer in Q2 2015 was Raymond James & Associates, an estimated $5.97M added.
  • The largest iShares US Pharmaceuticals ETF seller in Q2 2015 was Bank of Montreal, an estimated $54.5M sold.

Based on aggregated 13F filings for Q2 2015.